Clinical Trial Update: Anti-inflammatory Therapy With Anakinra in Newly Diagnosed Type 1 Diabetes [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial investigating anakinra (an anti-inflammatory IL-1 receptor antagonist) in newly diagnosed type 1 diabetes has completed phases 1 and 2 with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Anakinra (anakinra)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Type 1 Diabetes Mellitus | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-11-14